Engineering Chimeric Antigen Receptor T Cells to Treat Glioblastoma – Targeted Oncology
Targeted Oncology |
Engineering Chimeric Antigen Receptor T Cells to Treat Glioblastoma
Targeted Oncology Chimeric antigen receptors (CARs) are specialized molecules that can be expressed on the surface of T cells, allowing for redirected cytotoxicity against tumor antigens of interest. To date, the application of CAR T cells for GBM has been relatively … |
